Clinical outcome and paravalvular leakage of the new balloon‐expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 88, Iss. 3, 2016-09 ,pp. : 466-475

John Wiley & Sons Inc

Access to resources Recommend Favorite

Complications and Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement With Edwards SAPIEN & SAPIEN XT Valves: A Meta‐Analysis of World‐Wide Studies and Registries Comparing the Transapical and Transfemoral Accesses

By  

JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol. 28, Iss. 3, 2015-06 ,pp. : 266-278

John Wiley & Sons Inc

Access to resources Recommend Favorite

Can we predict postprocedural paravalvular leak after Edwards SAPIEN transcatheter aortic valve implantation?

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 1, 2015-07 ,pp. : 144-151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Percutaneous edwards SAPIEN™ valve implantation for significant pulmonary regurgitation after previous surgical repair with a right ventricular outflow patch

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 83, Iss. 3, 2014-02 ,pp. : 474-481

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fracturing a dysfunctional Edwards Perimount bioprosthetic valve to facilitate percutaneous valve‐in‐valve placement of SAPIEN 3 valve with modified delivery system

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 91, Iss. 1, 2018-01 ,pp. : 81-85

John Wiley & Sons Inc

Access to resources Recommend Favorite